Latest in FAIM
iiiiiiiii
March 1, 2023
at March 1, 2023Published by Editor’s Pick
A medical technology company with a technical pathology program capable of helping with research, drug development, global health solutions, and treatments.
Do you like it?
March 1, 2023
at March 1, 2023Published by Journal Club
Using Smartphones and Machine Learning to Quantify Parkinson's Disease Severity the Mobile Parkinson Disease Score
Do you like it?
March 1, 2023
at March 1, 2023Published by Wearable Devices
App that allows those with seizure disorders such as epilepsy to request help from emergency contacts when needed...
Do you like it?
March 1, 2023
at March 1, 2023Published by AI History
During the 90s AI winter, Expert Systems was launched, and ROBODOC was created as the first orthopedic surgical robot...
Do you like it?
March 1, 2023
at March 1, 2023Published by Leaders
A physician with a background in engineering is shaping the AI healthcare revolution in Singapore and creating a promising future...
Do you like it?
March 1, 2023
March 1, 2023
at March 1, 2023Published by News
Artificial Intelligence bests humans at predicting outcomes for brain radiotherapy patients and can identify potential therapeutic targets for cancer...
Do you like it?
March 1, 2023
at March 1, 2023Published by AI Technical
Cloud computing is a group of interconnected networks to share resources with storage as its primary use and many other applications...
Do you like it?
February 1, 2023
at February 1, 2023Published by Wearable Devices
Soft sensors for wireless fetal and maternal monitoring during either emergency or normal labor...
Do you like it?
Expert Interview
Dr. Sameer Mehta
Editor-In Chief & Founder
Sameer Mehta, MD, FACC, MBA, is a U.S. interventional cardiologist
Journal Club
Development and Validation of a Deep Learning Algorithm for Gleason Grading of Prostate Cancer from Biopsy Specimens
JAMA Network Open – Oncology – May 13, 2020
SIGN UP FOR OUR NEWSLETTER
Join our subscribers list to get the latest news and updates directly in your inbox.